Atlas Trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

Clinical trial NCT01456936 · COMPLETED

Trial details

NCT number
NCT01456936
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2011-11-01
Primary completion
2015-01-01
Enrollment
8144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.